Cerebral MR Spectroscopy Evaluation of the Neuroprotective Effects of Lithium and Olanzapine in Bipolar Affective Disorder Patients

dc.contributor.authors	Cumurcu, BE; Karlidag, R; Sarac, K; Unal, S; Ozcan, C; Erkorkmaz, U
dc.date.accessioned	2020-02-27T07:16:20Z
dc.date.available	2020-02-27T07:16:20Z
dc.date.issued	2008
dc.identifier.citation	Cumurcu, BE; Karlidag, R; Sarac, K; Unal, S; Ozcan, C; Erkorkmaz, U (2008). Cerebral MR Spectroscopy Evaluation of the Neuroprotective Effects of Lithium and Olanzapine in Bipolar Affective Disorder Patients. NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH, 15, 32-27
dc.identifier.issn	0941-9500
dc.identifier.uri	https://hdl.handle.net/20.500.12619/65093
dc.identifier.uri	https://doi.org/000207501600006
dc.description.abstract	We did not observe any change in cerebral NAA levels following lithium and olanzapine treatment in bipolar affective disorder patients in remission.
dc.language	English
dc.publisher	UNIVERSITATSVERLAG ULM GMBH
dc.title	Cerebral MR Spectroscopy Evaluation of the Neuroprotective Effects of Lithium and Olanzapine in Bipolar Affective Disorder Patients
dc.identifier.volume	15
dc.identifier.startpage	27
dc.identifier.endpage	32
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Temel Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Erkorkmaz, Ünal
dc.relation.journal	NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH
dc.identifier.wos	WOS:000207501600006
dc.contributor.author	Erkorkmaz, Ünal